乳酸脱氢酶和神经元特异性烯醇化酶水平与广泛期小细胞肺癌预后的关系

摘要

目的 通过分析广泛期小细胞肺癌(SCLC)患者治疗前乳酸脱氢酶(LDH)和神经元特异性烯醇化酶(NSE)与无进展生存(PFS)和总生存(OS)的关系,探讨其是否为影响广泛期SCLC患者的疗效预测和预后的因素.方法 本研究回顾性地分析了2008年3月至2014年9月于中国医科大学附属第一医院肿瘤内科住院治疗的广泛期SCLC患者83例.用Kaplan?Meier方法和Cox比例风险模型分析患者治疗前LDH和NSE与PFS和OS的关系,P<0.05为差异有统计学意义.结果 治疗前LDH水平与患者PFS(P=0.001)及OS(P=0.036)均显著相关,治疗前NSE水平与患者PFS(P=0.007)及OS(P=0.013)也显著相关.结论 LDH和NSE是影响广泛期SCLC患者疗效的预测因素和影响生存的预后因素.%Objective To determine whether neuron?specific enolase(NSE)affects the prognosis of extensive small cell lung cancer by analyz?ing the association between NSE before treatment and disease progression and overall survival of patients. Methods This study retrospectively an?alyzed 83 inpatients in the medical oncology department of the First Affiliated Hospital of China Medical University from March 2008 to September 2014. The Kaplan?Meier method and Cox proportional hazards models were used to analyze relevant factors affecting the prognosis of extensive small cell lung cancer;statistical significance was determined for a P value less than 0.05. Results The lactate dehydrogenase(LDH)level be?fore treatment was significantly associated with the progression?free survival(PFS)(P=0.001)and overall survival(OS)(P=0.036). The NSE level before treatment was also significantly associated with the PFS(P=0.007)and OS(P=0.013). Conclusion LDH and NSE affect progno?sis and survival of patients with extensive small cell lung cancer.